Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 23231926)

1.

Troubleshooting the rabbit ferric chloride-induced arterial model of thrombosis to assess in vivo efficacy of antithrombotic drugs.

Couture L, Richer LP, Mercier M, Hélie C, Lehoux D, Hossain SM.

J Pharmacol Toxicol Methods. 2013 Mar-Apr;67(2):91-7. doi: 10.1016/j.vascn.2012.11.003. Epub 2012 Dec 8.

PMID:
23231926
2.

Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.

Wong PC, Crain EJ, Watson CA, Zaspel AM, Wright MR, Lam PY, Pinto DJ, Wexler RR, Knabb RM.

J Pharmacol Exp Ther. 2002 Dec;303(3):993-1000.

3.

An optimized method to assess in vivo efficacy of antithrombotic drugs using optical coherence tomography and a modified Doppler flow system.

Couture L, Richer LP, Cadieux C, Thomson CM, Hossain SM.

J Pharmacol Toxicol Methods. 2011 Nov-Dec;64(3):264-8. doi: 10.1016/j.vascn.2011.09.001. Epub 2011 Sep 25.

PMID:
21967828
5.

[Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].

Ragni M, Golino P, Cirillo P, Pascucci I, Scognamiglio A, Ravera A, Esposito N, Battaglia C, Guarino A, Chiariello M.

Cardiologia. 1996 Jan;41(1):51-8. Italian.

PMID:
8697470
6.

Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis.

Heran C, Morgan S, Kasiewski C, Bostwick J, Bentley R, Klein S, Chu V, Brown K, Colussi D, Czekaj M, Perrone M, Leadley R Jr.

Eur J Pharmacol. 2000 Feb 18;389(2-3):201-7.

PMID:
10688985
7.

Differential effects of sodium nitroprusside and hydralazine in a rat model of topical FeCl3-induced carotid artery thrombosis.

Robinson MA, Welsh DC, Bickel DJ, Lynch JJ, Lyle EA.

Thromb Res. 2003;111(1-2):59-64.

PMID:
14644081
8.

Rat model of arterial thrombosis induced by ferric chloride.

Kurz KD, Main BW, Sandusky GE.

Thromb Res. 1990 Nov 15;60(4):269-80.

PMID:
2087688
9.

The Fab-fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis.

van Giezen JJ, Wahlund G, Nerme, Abrahamsson T.

Thromb Haemost. 1997 May;77(5):964-9.

PMID:
9184411
10.

Algal fucoidan, unlike heparin, has thrombolytic activity in a murine arterial thrombosis model.

Min SK, Han SM, Kim HT, Kwon OC, Lee S, Kim JK.

Blood Coagul Fibrinolysis. 2012 Jul;23(5):359-66. doi: 10.1097/MBC.0b013e3283518815.

PMID:
22576287
11.
12.

The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis.

Cho JH, Yun CH, Seo HS, Koga T, Dan T, Koo BA, Kim HY.

Thromb Haemost. 2001 Dec;86(6):1512-20.

PMID:
11776321
13.

Adaptation of the Folts and electrolytic methods of arterial thrombosis for the study of anti-thrombotic molecules in small animals.

Sturgeon SA, Jones C, Angus JA, Wright CE.

J Pharmacol Toxicol Methods. 2006 Jan-Feb;53(1):20-9. Epub 2005 Aug 8.

PMID:
16087355
14.

Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.

Berry CN, Girard D, Girardot C, Lochot S, Lunven C, Visconte C.

Semin Thromb Hemost. 1996;22(3):233-41.

PMID:
8836007
15.

Optimization of ferric chloride induced thrombosis model in rats: effect of anti-platelet and anti-coagulant drugs.

Surin WR, Prakash P, Barthwal MK, Dikshit M.

J Pharmacol Toxicol Methods. 2010 May-Jun;61(3):287-91. doi: 10.1016/j.vascn.2009.11.002. Epub 2009 Dec 2.

PMID:
19961942
16.

Activity of a sub-cutaneously administered novel mixed micellar formulation of argatroban in rat and rabbit models of venous thrombosis.

Berry CN, Visconte C, Lecoffre C, Lochot S, Girard D.

Thromb Haemost. 2000 Aug;84(2):286-90.

PMID:
10959702
17.

Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis.

Golino P, Ragni M, Cirillo P, D'Andrea D, Scognamiglio A, Ravera A, Buono C, Ezban M, Corcione N, Vigorito F, Condorelli M, Chiariello M.

Circ Res. 1998 Jan 9-23;82(1):39-46.

18.

Orally administered heparins prevent arterial thrombosis in a rat model.

Pinel C, Wice SM, Hiebert LM.

Thromb Haemost. 2004 May;91(5):919-26.

PMID:
15116252
19.

Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.

Duval N, Lunven C, O'Brien DP, Grosset A, O'Connor SE, Berry CN.

Br J Pharmacol. 1996 Jun;118(3):727-33.

20.

Ferric chloride-induced murine carotid arterial injury: A model of redox pathology.

Li W, McIntyre TM, Silverstein RL.

Redox Biol. 2013 Jan 26;1:50-5. doi: 10.1016/j.redox.2012.11.001. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk